Literature DB >> 17449463

The blood-brain barrier for catecholamines - revisited.

Richard M Kostrzewa1.   

Abstract

Although it is well-recognized that catecholamines are generally unable to penetrate the developed blood-brain barrier (BBB) to gain entry into brain, except at circumventricular sites where the BBB is absent or deficient, ontogenetic development of this barrier seems to have escaped systematic study. To explore BBB development, several approaches were used. In the first study rats were treated once on a specific day of postnatal ontogeny, as early as the day of birth, with the neurotoxin 6-hydroxydopamine (6-OHDA; 60 mg/kg), and then terminated in adulthood for regional analysis of endogenous norepinephrine (NE) content of brain. In another study, rats were treated once, on a specific day of postnatal ontogeny, with the BBB-permeable neurotoxin 6-hydroxydopa (6-OHDOPA; 60 mg/kg) following pretreatment with the BBB-impermeable amino acid decarboxylase inhibitor carbidopa (100 mg/kg IP), then terminated in adulthood for regional analysis of endogenous NE content of brain. In the third study rats were treated once, on a specific day of postnatal ontogeny, with the analog [3H]metaraminol, and terminated 1 hour later for determination of regional distribution of tritium in brain. On the basis of [3H]metaraminol distribution and NE depletions after neurotoxin treatments, it is evident that the BBB in neocortex, striatum, cerebellum and other brain regions forms in stages over a period of at least 2 weeks from birth. Moreover, because the BBB consists of several element (physical-, ion-restrictive-, and enzymatic-barrier), the method employed will derive data mainly applicable to the targeted aspect of the barrier, which may or may not necessarily coincide with elements of the barrier that have a different rate of ontogenetic development. Accordingly, it is evident that some aspects of physical- and ion-restrictive elements of the BBB form within approximately the first week after birth in rat neocortex and striatum, while enzymatic elements of the BBB form more than than 2 weeks later. Regardless, the BBB forms at earlier times in forebrain vs hindbrain regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449463     DOI: 10.1007/bf03033571

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  18 in total

1.  PHYSIOLOGICAL DISPOSITION OF H3-NOREPINEPHRINE IN THE DEVELOPING RAT.

Authors:  J GLOWINSKI; J AXELROD; I J KOPIN; R J WURTMAN
Journal:  J Pharmacol Exp Ther       Date:  1964-10       Impact factor: 4.030

2.  The uptake of circulating [3H]norepinephrine by the pituitary gland and various areas of the brain.

Authors:  H WEIL-MALHERBE; L G WHITBY; J AXELROD
Journal:  J Neurochem       Date:  1961-10       Impact factor: 5.372

3.  The physiological disposition of H3-epinephrine and its metabolite metanephrine.

Authors:  J AXELROD; H WEIL-MALHERBE; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1959-12       Impact factor: 4.030

4.  Development of the blood-brain barrier for 6-hydroxydopamine.

Authors:  C Sachs
Journal:  J Neurochem       Date:  1973-06       Impact factor: 5.372

5.  The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.

Authors:  C C Porter; J A Totaro; A Burcin
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

6.  Critical periods for noradrenergic regeneration in rat brain regions following neonatal subcutaneous 6-hydroxydopamine.

Authors:  R H Schmidt; R K Bhatnagar
Journal:  Life Sci       Date:  1979-11-05       Impact factor: 5.037

7.  Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa.

Authors:  R M Kostrzewa; R E Garey
Journal:  Brain Res       Date:  1977-03-25       Impact factor: 3.252

8.  Mechanisms of selective depletion of brain regional noradrenaline by systemic 6-hydroxydopamine in newborn rats.

Authors:  M C Liew; R Laverty
Journal:  Eur J Pharmacol       Date:  1975-08       Impact factor: 4.432

9.  Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.

Authors:  R M Kostrzewa
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-08

10.  Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat.

Authors:  L A Loizou
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

View more
  11 in total

1.  Visceral sensitization in postural tachycardia syndrome.

Authors:  Ramesh K Khurana
Journal:  Clin Auton Res       Date:  2014-02-09       Impact factor: 4.435

Review 2.  Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.

Authors:  Luca Magistrelli; Cristoforo Comi
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

Review 3.  Epinephrine: a short- and long-term regulator of stress and development of illness : a potential new role for epinephrine in stress.

Authors:  Dona Lee Wong; T C Tai; David C Wong-Faull; Robert Claycomb; Edward G Meloni; Karyn M Myers; William A Carlezon; Richard Kvetnansky
Journal:  Cell Mol Neurobiol       Date:  2011-11-17       Impact factor: 5.046

4.  Gene expression and content of enzymes of noradrenaline synthesis in the rat organ of Zuckerkandl at the critical period of morphogenesis.

Authors:  A R Murtazina; Yu O Nikishina; N S Bondarenko; A Ya Sapronova; E V Volina; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2017-07-20       Impact factor: 0.788

5.  Ozone-induced dysregulation of neuroendocrine axes requires adrenal-derived stress hormones.

Authors:  Andres R Henriquez; John S House; Samantha J Snow; Colette N Miller; Mette C Schladweiler; Anna Fisher; Hongzu Ren; Matthew Valdez; Prasada R Kodavanti; Urmila P Kodavanti
Journal:  Toxicol Sci       Date:  2019-08-09       Impact factor: 4.109

6.  Cognitive Performance Enhancement Induced by Caffeine, Carbohydrate and Guarana Mouth Rinsing during Submaximal Exercise.

Authors:  Laura Pomportes; Jeanick Brisswalter; Laurence Casini; Arnaud Hays; Karen Davranche
Journal:  Nutrients       Date:  2017-06-09       Impact factor: 5.717

7.  Adrenergic agonist induces rhythmic firing in quiescent cardiac preganglionic neurons in nucleus ambiguous via activation of intrinsic membrane excitability.

Authors:  Isamu Aiba; Jeffrey L Noebels
Journal:  J Neurophysiol       Date:  2019-01-30       Impact factor: 2.714

8.  Unpredictable stress delays recovery from exercise-induced muscle pain: contribution of the sympathoadrenal axis.

Authors:  Pedro Alvarez; Paul G Green; Jon D Levine
Journal:  Pain Rep       Date:  2019-09-18

9.  Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.

Authors:  Junghwa Ryu; Rui Zhang; Bo-Hyun Hong; Eun-Jung Yang; Kyoung Ah Kang; Moonseok Choi; Ki Cheon Kim; Su-Jin Noh; Hee Soo Kim; Nam-Ho Lee; Jin Won Hyun; Hye-Sun Kim
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature.

Authors:  Logan Froese; Joshua Dian; Alwyn Gomez; Bertram Unger; Frederick A Zeiler
Journal:  Pharmacol Res Perspect       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.